Syn-lethality : an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies

Synthetic lethality (SL) is a novel strategy for anticancer therapies, whereby mutations of two genes will kill a cell but mutation of a single gene will not. Therefore, a cancer-specific mutation combined with a drug-induced mutation, if they have SL interactions, will selectively kill cancer cells...

Full description

Saved in:
Bibliographic Details
Main Authors: Li, Xue-juan, Mishra, Shital K., Wu, Min, Zhang, Fan, Zheng, Jie
Other Authors: School of Computer Engineering
Format: Article
Language:English
Published: 2014
Subjects:
Online Access:https://hdl.handle.net/10356/101761
http://hdl.handle.net/10220/19741
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-101761
record_format dspace
spelling sg-ntu-dr.10356-1017612022-02-16T16:31:06Z Syn-lethality : an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies Li, Xue-juan Mishra, Shital K. Wu, Min Zhang, Fan Zheng, Jie School of Computer Engineering Bioinformatics Research Centre DRNTU::Science::Medicine::Biomedical engineering Synthetic lethality (SL) is a novel strategy for anticancer therapies, whereby mutations of two genes will kill a cell but mutation of a single gene will not. Therefore, a cancer-specific mutation combined with a drug-induced mutation, if they have SL interactions, will selectively kill cancer cells. While numerous SL interactions have been identified in yeast, only a few have been known in human. There is a pressing need to systematically discover and understand SL interactions specific to human cancer. In this paper, we present Syn-Lethality, the first integrative knowledge base of SL that is dedicated to human cancer. It integrates experimentally discovered and verified human SL gene pairs into a network, associated with annotations of gene function, pathway, and molecular mechanisms. It also includes yeast SL genes from high-throughput screenings which are mapped to orthologous human genes. Such an integrative knowledge base, organized as a relational database with user interface for searching and network visualization, will greatly expedite the discovery of novel anticancer drug targets based on synthetic lethality interactions. The database can be downloaded as a stand-alone Java application. Published version 2014-06-13T03:35:07Z 2019-12-06T20:44:11Z 2014-06-13T03:35:07Z 2019-12-06T20:44:11Z 2014 2014 Journal Article Li, X.-j., Mishra, S. K., Wu, M., Zhang, F., & Zheng, J. (2014). Syn-Lethality: An Integrative Knowledge Base of Synthetic Lethality towards Discovery of Selective Anticancer Therapies. BioMed Research International, 2014, 196034-. 2314-6133 https://hdl.handle.net/10356/101761 http://hdl.handle.net/10220/19741 10.1155/2014/196034 24864230 en BioMed research international © 2014 Xue-juan Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic DRNTU::Science::Medicine::Biomedical engineering
spellingShingle DRNTU::Science::Medicine::Biomedical engineering
Li, Xue-juan
Mishra, Shital K.
Wu, Min
Zhang, Fan
Zheng, Jie
Syn-lethality : an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies
description Synthetic lethality (SL) is a novel strategy for anticancer therapies, whereby mutations of two genes will kill a cell but mutation of a single gene will not. Therefore, a cancer-specific mutation combined with a drug-induced mutation, if they have SL interactions, will selectively kill cancer cells. While numerous SL interactions have been identified in yeast, only a few have been known in human. There is a pressing need to systematically discover and understand SL interactions specific to human cancer. In this paper, we present Syn-Lethality, the first integrative knowledge base of SL that is dedicated to human cancer. It integrates experimentally discovered and verified human SL gene pairs into a network, associated with annotations of gene function, pathway, and molecular mechanisms. It also includes yeast SL genes from high-throughput screenings which are mapped to orthologous human genes. Such an integrative knowledge base, organized as a relational database with user interface for searching and network visualization, will greatly expedite the discovery of novel anticancer drug targets based on synthetic lethality interactions. The database can be downloaded as a stand-alone Java application.
author2 School of Computer Engineering
author_facet School of Computer Engineering
Li, Xue-juan
Mishra, Shital K.
Wu, Min
Zhang, Fan
Zheng, Jie
format Article
author Li, Xue-juan
Mishra, Shital K.
Wu, Min
Zhang, Fan
Zheng, Jie
author_sort Li, Xue-juan
title Syn-lethality : an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies
title_short Syn-lethality : an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies
title_full Syn-lethality : an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies
title_fullStr Syn-lethality : an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies
title_full_unstemmed Syn-lethality : an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies
title_sort syn-lethality : an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies
publishDate 2014
url https://hdl.handle.net/10356/101761
http://hdl.handle.net/10220/19741
_version_ 1725985548836798464